13th International Conference on Environmental Mutagens
Maintaining Genomic Health in a Changing World
53rd Annual Meeting of the EMGS
August 27 - September 1, 2022 - Ottawa Canada
About
ICEM 2022 Sponsors
Become a Sponsor
Diamond Level:
Morningside Foundation
NIEHS R13 Grant No. 5R13ES031435-03
TwinStrand Biosciences
Platinum Level:
Escher Fund for Autism
Health and Environmental Sciences Institute
Proctor & Gamble, Co.
US-FDA R13 Grant No. 5R13FD006702-04
University of Ottawa
MGI Americas Inc.
Carleton University
Gold Level:
Bristol Myers Squibb
Canadian Institutes for Health Research
Inotiv Inc.
Silver Level:
Burroughs Wellcome Fund
Elsevier
United Kingdom Environmental Mutagen Society
Gilead Sciences
National Cancer Institute (NCI)
Merck Research
Bronze Level:
Lhasa Limited
The Research Institute for Fragrance Materials
Moltox, Molecular Toxicology, Inc.
BASF Corp.
Toxys B.V.
Litron Laboratories
Instem
Kao Corporation
MultiCASE
Supporter
Mutagen-Brasil
Johnson & Johnson
University of Michigan
John J. Nicolette, MS, DABT
Contributors
European Environmental Mutagenesis and Genomics Society
Japanese Environmental Mutagen and Genome Society
Journal of Biochemistry
Illumina
Pfizer Inc.
Environmental and Molecular Mutagenesis Journal
Bill Kaufmann, PhD
Genetic Toxicology Association
Society of Toxicology
SIG MEETINGS
SUNDAY, AUGUST 28
DNA Repair SIG Meeting: 7AM to 8AM | Governor General I - Level 4 | View Agenda
Chair: Aishwarya Prakash, PhD, University of South Alabama, Mobile, AL, USA
Co-Chair: Amy Michelle Whitaker, PhD, Fox Chase Cancer Center, Philadelphia, PA, USA
SNI Co-Chari: Ryan Barnes, PhD, University of Pittsburgh, Pittsburgh, PA, USA
Germ Cell and Heritable Effects SIG Meeting: 7AM to 8AM | Governor General II - Level 4 | View Agenda
Chair: Jonatan Axelsson, MD, PhD, Lund University and Skåne University Hospital, Malmö, Sweden
Co-Chairs: Habib A. Shojaei Saadi DVM, PhD, Health Canada, Ottawa, ON, Canada, Mathia L Colwell, University of Minnesota, St. Paul, MN, USA
MONDAY, AUGUST 29
Genomics and Data Sciences SIG Meeting: 7AM to 8AM | Governor General I - Level 4 View Agenda
Co-Chairs: Matthew Meier, Health Canada, Ottawa, ON, Canada, Christopher Faulk, PhD, University of Minnesota, St. Paul, MN, USA, Tess C Leuthner, Duke University, Durham, NC, USA
Applied Genetic Toxicology SIG Meeting: 7AM to 8AM | Governor General II - Level 4
Chair: Daniel J Roberts, MS, Charles River Laboratories, Skokie, IL, USA
Co-Chair: Alexandra S. Long, PhD, Health Canada, Ottawa, ON, USA
SNI Co-Chair: Eunnara Cho, Health Canada, Ottawa, ON, USA
TUESDAY, AUGUST 30
Genotoxicity Risk Assessment and Public Health SIG Meeting: 7AM to 8AM | Governor General I - Level 4 | View Agenda
Chair: Catherine Gibbons, PhD, US EPA, Washington D.C., USA
Co-Chairs: Marc Andrew Beal, PhD, MSc & Julie Cox, Health Canada, Ottawa, ON, Canada,
In Vivo Mutagenesis SIG Meeting: 7AM to 8AM | Governor General II - Level 4 | View Agenda
Chair: Mark Fielden, PhD, Kate Therapeutics, San Diego, CA, USA
Co-Chairs: Charles C Valentine, III, M.Sc., TwinStrand Biosciences, Seattle, WA, USA, Shaofei Zhang, Pfizer, Groton, CT, USA
WEDNESDAY, AUGUST 31
Epigenomics SIG Meeting: 7AM to 8AM | Governor General I - Level 4 | View Agenda
Chair: Isabelle R. Miousse, PhD, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Co-Chair: Brian N Chorley, PhD, US EPA, Raleigh, NC, USA
SNI Co-Chair: Nicole Wanner, DVM, University of Minnesota Twin Cities, St. Paul, MN, USA